AW
IONS icon

Alpha Windward’s Ionis Pharmaceuticals IONS Stock Holding History

Alpha Windward’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-324
Closed -$13K – 431
2016
Q1 		$13K Hold
324
– – 0.01% 380
2015
Q4 		$20K Buy
+324
New +$17.5K 0.01% 364

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Alpha Windward's IONS Position: Q2 2016 in Review

Alpha Windward sold out of Ionis Pharmaceuticals (IONS) in Q2 2016, closing a stake of 324 shares — an estimated $13K sold.

Alpha Windward first reported a position in IONS in Q4 2015 and held it in 2 quarters. The position peaked at $20K in Q4 2015. 282 funds tracked by Wall St. Rank hold IONS as of Q2 2016.

  • Alpha Windward reported no remaining Ionis Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Alpha Windward sold 324 Ionis Pharmaceuticals shares in Q2 2016, an estimated $13K.
  • Alpha Windward first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 2 quarters.
  • Alpha Windward's Ionis Pharmaceuticals position peaked at $20K in Q4 2015.
  • 282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2016.

Based on Alpha Windward's 13F filing for Q2 2016, filed 8 Jul 2016.